Status
Conditions
Treatments
About
The goal of this clinical trial is to learn if Quick Release dynamic strengthening of the cervical spine extensor muscles' reflex could improve dynamic stabilisation capacities of the cervical spine by reducing muscle activation delay in amateurs rugby players. The main questions it aims to answer are described as follows:
The primary outcome measure is the comparison between the intervention and control groups of the variation in activation delay of the cervical spine extensor muscles in milliseconds (ms) between the beginning and the end of the strengthening program. The activation delay in milliseconds corresponds to the time between the onset of impact application on the head and the onset of reactive muscle force production measured by the Cervistab© ergometer.
The secondary outcomes are also a comparison between the two groups of the variations from the beginning to the end of the strengthening program for the followings parameters, measured during with the Cervistab© machine:
Researchers will compare the intervention group to a distractor (control) arm to see if our training protocol has an impact on the activation delay.
Full description
Rugby authorities are seeking preventive measures to reduce cranio-cervical injuries. Literature suggests that early and strong contraction of cervical spine muscles could decrease this risk. The Quick Release principle, using maximal isometric contractions and non-impact disturbances, might improve the dynamic stabilization of the cervical spine. No study has yet evaluated the effect of muscle strengthening programs on this stabilization.
It is hypothesized that specific training of the cervical spine extensor muscles could reduce activation delay and increase reflexive force.
This study is a single-centre, controlled, randomised, and stratified based on activation delay.
It is an open study with blind evaluation. Randomization will be stratified based on the activation delay of the cervical spine extensor muscles into two sub-groups (slow and fast), measured during the Cervistab© test at the inclusion visit.
Researchers propose an open-label study with blind evaluation: The principal investigator, who will conduct the pre- and post-training protocol tests, will not be involved in the training protocol (conducted by the associated investigator) and will therefore not know which program the tested subject completed.
Both groups will undergo a foundational cervical muscle strengthening regimen, which includes classic isometric contraction strengthening (duration = 20 minutes) at the beginning of their training session.
The second part of each training session will depend on the group to which they have been randomised (also 20 minutes):
Both groups will do 10 trainings of 40 minutes dispatched on one month.
Cervistab ergometer is a machine developped by the main investigator and engineers that records force (in newton) as a function of time. It delivers impacts over the head of the subject. Each subject puts himself in "scrum" position and take small impacts over the head and we can measure the reflex force production rate after the activation delay.
Distractor arm : The comparison group will have to do useful tasks for their rugby practice that does not have an impact on the primary outcome. Here, researchers will ask the comparison group to use stroboscopic glasses to train their decision skills in catching and throwing rugby balls. The stroboscopic glasses switch from bright to dark at a certain frequency and hence, reduce the amount of visual information.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria:
Non Inclusion Criteria :
Primary purpose
Allocation
Interventional model
Masking
50 participants in 2 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal